{
    "title": "After hep C cure, companies target next big liver disease market",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2827363/After-hep-C-cure-companies-target-big-liver-disease-market.html",
    "date": "2014-11-09",
    "keywords": [
        "liver",
        "drug",
        "disease",
        "hepatitis",
        "cirrhosis",
        "nash",
        "phase",
        "trial",
        "fibrosis",
        "university",
        "hospital",
        "cure",
        "market",
        "c",
        "gilead",
        "b",
        "treatment",
        "program",
        "hepatology",
        "inflammation",
        "research",
        "fda",
        "bill",
        "york",
        "attention",
        "year",
        "half",
        "director",
        "indiana",
        "percent",
        "alcohol",
        "abuse",
        "midstage",
        "damage",
        "development",
        "raptor",
        "collagen",
        "faint",
        "goal",
        "failure",
        "company",
        "bernstein",
        "class",
        "gmt",
        "november",
        "email",
        "nov",
        "inc",
        "success",
        "obesity",
        "foundation",
        "scarring",
        "cause",
        "industry",
        "saidmost",
        "course",
        "yeargilead",
        "sovaldi",
        "quarter",
        "bet",
        "wave",
        "gastroenterology",
        "indianapolis",
        "steatohepatitis",
        "condition",
        "patient",
        "weight",
        "mauricio",
        "washington",
        "school",
        "medicine",
        "st",
        "louisintercept",
        "acid",
        "progression",
        "one",
        "effect",
        "population",
        "pack",
        "sense",
        "executive",
        "mark",
        "scott",
        "dean",
        "discovery",
        "mt",
        "field",
        "sort",
        "leapfrogged",
        "friedman",
        "function",
        "bar",
        "business",
        "competition",
        "antibody",
        "simtuzumab",
        "enzyme",
        "loxl2",
        "scar",
        "tissue"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}